KOBAYASHI, A., NISHINOMIYA F., FUKAMACHI, Y., OHTAKA, M., YAMAMOTO, J., TAKAGI, K., TANAKA, S., TAKIZAWA, S., IMADACHI, H., FUKASE, M., SHIHIZU, Y. and HAYASAKA, K. A Case of Glycogen Storage Disease Type III (Glycogen Debranching Enzyme Deficiency) with Liver Cirrhosis and Hypertrophic Cardiomyopathy. Tohoku J. Exp. Med., 1995, 176 (3), [181] [182] [183] [184] [185] We present a 26-year-old woman with glycogen storage disease type III (debranching enzyme deficiency) complicated with liver cirrhosis and hypertrophic Cardiomyopathy. Glycogen debranching enzyme has two catalytic sites, oligo-1, 4,-1, 4-glucantransferase (EC 2.4.1.25) and amylo-1, 6-glucosidase (EC 3.2.1.33). Variability in the clinical phenotype could be a function of the involvement of one or other catalytic site, or differences in tissue expression of the defective enzyme, or both. We hypothesize that some subtypes of glycogen storage disease (GSD) type III may cause liver cirrhosis as seen in GSD type IV due to the accumulation of glycogen of abnormal structure.
glycogen storage disease; debranching enzyme; liver cirrhosis Glycogen storage disease (GSD) type III is an autosomal recessive disorder caused by a deficiency of glycogen debranching enzyme, which leads to the storage of an abnormal glycogen with short outer chains in liver and in skeletal and heart muscle (Hers et al. 1989 ). Patients with GSD type III show variable clinical manifestations and are classified into several subtypes depending on the differences in tissue expression of the defective enzyme (Van Hoof and Hers 1967). In general, the prognosis of GSD type III has not been considered to be serious (Hers et al. 1989; Coleman et al. 1992) . We report here a case complicated with liver cirrhosis and hypertrophic cardiomyopathy.
CASE REPORT
This Japanese patient was born by spontaneous vaginal delivery of term. Her parents were healthy, but they were first cousins. Early growth and developmental milestones were normal. She was admitted for evaluation of abdominal distension at 21 months of age. She had a doll-like face and a markedly enlarged liver (10 cm below the right costal margin) without splenomegaly. Laboratory findings showed an elevation of serum transaminases (aspartate aminotransferase 352 IU/liter, alanine aminotransferase 400 IU/liter) and hypoglycemia (2.1 mmol/ liter) at fasting, but without any symptoms of hypoglycemia. Because of persistent hepatomegaly and elevation of transaminases, a liver biopsy was performed, which showed an accumulation of glycogen, periportal fibrosis, and regeneration nodules (Fig. 1) . She was followed as an unknown type GSD without any enzymatic analysis, but was subsequently lost to follow-up. At 23 years of age she had a healthy baby by cesarean delivery. She presented to Shounai Amarume Hospital at 23 years of age because of a right inguinal swelling. Height was 165 cm and body weight was 66 kg. In addition to a right inguinal hernia, she showed hepatomegaly with the liver palpable 10 cm below the right costal margin, and splenomegaly with the spleen palpable 7 cm below the left costal margin. Normal investigations included C-reactive protein, red blood cell count, hemoglo- Fig .1 (Normal range <10). Blood pressure was 122/64 and cardiac enlargement was not detected on x-ray. However, the ECG showed evidence of left ventricular hypertrophy (increased QRS voltage in the precordial leads), and was suggestive of myocardial damage (inverted T waves in I, aVF, and V2-V6). Echocardiography revealed marked thickening of the interventricular septum. Ultrasound and computed tomography of the abdomen showed hepatomegaly with an irregular surface ( Fig. 2) and splenomegaly. No ascites was seen. The gastroscopy showed no esophageal varices. Enzymatic analysis of debranching enzyme in leukocytes using limit dextran as substrate (Chen et al. 1987) showed no detectable activity. 
DISCUSSION
We present a 26-year-old woman with liver type of GSD complicated with liver cirrhosis and hypertrophic cardiomyopathy.
She had normal level of serum uric acid, blood lactate at fasting and phosphorylase kinase activity in leukocytes (data not shown), and was diagnosed as GSD type III (debranching enzyme deficiency) based on the enzymatic analysis and clinical manifestation. GSD type III has been usually considered to follow a mild clinical course compared with GSD type I, and progression to cirrhotic liver failure has only rarely been reported (Fellows et al. 1983; Markowitz et al. 1993 ). However cirrhosis has been observed in three other Japanese patients (Shimizu et al. 1982; Hibi et al. 1983 ; Sato personal communication).
One of the reported cases (Shimizu et al. 1982 ) died of liver cancer. The patient reported in this paper has had no symptoms of hepatic and muscular involvement except for hepatomegaly.
The histopathology, however, of the liver biopsy taken in infancy, which included extensive fibrosis and regeneration nodules, would have predicted progression to cirrhotic liver failure. The clinical manifestations of these four Japanese cases seems to be different from previous reports. Patients with GSD type III have been classified into several subtypes depending on the differences in tissue expression of the enzymes (Van Hoof and Hers 1967). Glycogen debranching enzyme has two catalytic sites, oligo-1, 4,-1, 4-glucantransferase (EC 2.4.1.25) and amylo-1, 6-glucosidase (EC 3.2.1.33) (Hers et al. 1989 ). In addition to the difference in tissue expression of defective enzyme, the clinical course could also be determined by the differential involvement of these two catalytic sites. Alternatively, accumulation of glycogen of abnormal structure would cause liver cirrhosis as in GSD type IV (Hers et al. 1989 ). Molecular analysis and in vitro expression studies should be performed to clarify the genotype-phenotype correlations.
